EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition

Xiaocui Liang, Shan Zhou, Zefeng Xiao

Aging · 15.09.2023 · 15 (17) · 8770-8781

DOI: 10.18632/aging.204996 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Aging, online erschienen am 05.09.2023. Verfasst von Xiaocui Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Wuhan No. 1 Hospital, Wuhan 430023, Hubei Province, China. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We performed the meta-analysis to explore the predictive value of lactate dehydrogenase (LDH) levels in uveal melanoma (UM) patients receiving immune checkpoint inhibitors (ICIs). METHODS: Eligible articles were obtained through EMBASE, PubMed, Google Scholar, and the Cochrane Library, until March 23, 2023. The clinical outcomes evaluated in this study encompassed overall survival (OS) and progression-free survival (PFS). RESULTS: This meta-analysis comprised eight studies with a combined total of 383 patients. The results showed that patients with high LDH levels had noticeably worse OS (HR: 3.445, 95% CI: 2.504-4.740, p < 0.001) and PFS (HR: 1.720, 95% CI: 1.429-2.070, p < 0.001). Subgroup analysis confirmed that the upper limit of normal was the ideal cut-off value for LDH. In multivariate analysis, we also found that high LDH levels significantly predicted shorter OS (HR: 3.405, 95% CI: 1.827-6.348, p < 0.001) and PFS (HR: 2.519, 95% CI: 1.557-4.076, p < 0.001) in UM patients. The sensitivity analysis and publication bias test supported the reliability of our results. CONCLUSIONS: In UM patients treated with ICIs, the LDH levels were reliable indicators of prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

L-Lactate DehydrogenaseImmune Checkpoint InhibitorsPrognosisReproducibility of ResultsUveal NeoplasmsHumansMelanomaUveal Melanoma

Stichwörter der Autor:innen

immune checkpoint inhibitorslactate dehydrogenaseprognosisuveal melanoma

Substanzen

Immune Checkpoint InhibitorsL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Ophthalmology, Wuhan No. 1 Hospital, Wuhan 430023, Hubei Province, China.
  • Department of Ophthalmology, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan 430023, Hubei Province, China.

Zitieren

APA

Liang, X., Zhou, S., & Xiao, Z. (2023). Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition. Aging, 15(17), 8770-8781. https://doi.org/10.18632/aging.204996

Vancouver

Liang X, Zhou S, Xiao Z. Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition. Aging. 2023;15(17):8770-8781. doi:10.18632/aging.204996

BibTeX
@article{Liang2023,
  author = {Liang, Xiaocui and Zhou, Shan and Xiao, Zefeng},
  title = {Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition},
  journal = {Aging},
  year = {2023},
  volume = {15},
  number = {17},
  pages = {8770--8781},
  doi = {10.18632/aging.204996}
}
Kostenlos starten →